Estados financieros detallados de Sintx Technologies, Inc. (SINT): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Sintx Technologies, Inc. registró ingresos de $1.0M en el último ejercicio fiscal, con un CAGR de 5 años del 11.4%.
Márgenes de los últimos 12 meses: margen bruto -4.6%, margen operativo -8.5%, margen neto -13.0%.
Al precio actual de $1.68, SINT presenta beneficios negativos (P/E no significativo) y un ROE del -5.66%. La capitalización bursátil es de $11M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $15.2M | $11.2M | $95000 | $689000 | $594000 | $606000 | $601000 | $2.6M | $1.2M | $1.0M |
| Coste de Ventas | $3.8M | $6.4M | $56000 | $551000 | $475000 | $449000 | $265000 | $784000 | $811000 | $1.2M |
| Beneficio Bruto | $11.4M | $4.9M | $39000 | $138000 | $119000 | $157000 | $336000 | $1.8M | $435000 | -$201000 |
| I+D | $6.3M | $5.1M | $3.0M | $3.4M | $4.8M | $5.9M | $6.5M | $8.7M | $5.2M | $4.6M |
| Generales y Administrativos | $16.6M | $10.9M | $4.7M | $3.3M | $5.1M | $4.9M | $5.3M | $5.4M | $4.6M | $6.4M |
| Gastos Operativos | $23.0M | $15.9M | $7.7M | $6.7M | $8.6M | $10.8M | $11.7M | $15.2M | $14.5M | $10.5M |
| Beneficio Operativo | -$11.5M | -$11.1M | -$13.1M | -$6.6M | -$8.5M | -$10.6M | -$11.3M | -$13.4M | -$14.0M | -$10.7M |
| EBITDA | -$8.3M | -$11.1M | -$8.2M | -$4.3M | -$6.5M | -$8.6M | -$11.1M | -$6.6M | -$9.6M | -$9.7M |
| Gastos por Intereses | $4.5M | $1.3M | $1.4M | $4000 | $2000 | $25000 | $17000 | $2000 | $29000 | $52000 |
| Beneficio Antes de Impuestos | -$16.6M | -$9.3M | -$9.7M | -$4.8M | -$7.0M | -$9.3M | -$12.0M | -$8.3M | -$11.0M | -$10.4M |
| Impuestos | $6.3M | $1.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $6.7M |
| Beneficio Neto | -$16.6M | -$9.3M | -$8.7M | -$4.8M | -$7.0M | -$9.3M | -$12.0M | -$8.3M | -$11.0M | -$17.1M |
| BPA | $-32255.41 | $-9395.07 | $-2373.00 | $-311.65 | $-44.57 | $-47.59 | $-54.67 | $-35.43 | $-14.87 | $-6.16 |
| BPA Diluido | $-32255.41 | $-9395.07 | $-2253.98 | $-311.65 | $-41.92 | $-39.75 | $-51.96 | $-19.42 | $-15.19 | $-6.16 |
| Acciones en Circulación (Diluidas) | $515 | $993 | $3839 | $15559 | $174461 | $247102 | $317323 | $425211 | $744781 | $2.8M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $6.9M | $539000 | $5.4M | $1.8M | $25.4M | $14.3M | $6.2M | $3.3M | $3.6M | $4.1M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $1.6M | $1.2M | $1.3M | $1.9M | $1.9M | $102000 | $328000 | $685000 | $196000 | $178000 |
| Inventario | $7.2M | $1.2M | $52000 | $106000 | $99000 | $303000 | $284000 | $888000 | $502000 | $825000 |
| Activos Corrientes | $16.0M | $3.2M | $7.0M | $4.1M | $27.6M | $15.0M | $7.2M | $5.5M | $4.8M | $5.7M |
| Inmovilizado Material | $889000 | $1.4M | $124000 | $2.5M | $2.4M | $6.4M | $8.0M | $8.9M | $4.1M | $2.9M |
| Fondo de Comercio | $6.2M | $6.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $302000 |
| Activos Intangibles | $3.2M | $2.7M | $46000 | $41000 | $36000 | $31000 | $26000 | $21000 | $16000 | $142000 |
| Activos Totales | $26.3M | $14.6M | $11.5M | $9.1M | $30.4M | $21.8M | $15.8M | $15.4M | $9.4M | $9.5M |
| Cuentas por Pagar | $658000 | $1.7M | $301000 | $191000 | $194000 | $241000 | $434000 | $636000 | $299000 | $382000 |
| Deuda a Corto | $7.0M | $605000 | 0 | $6000 | $109000 | $509000 | $898000 | $558000 | $32000 | $7000 |
| Pasivos Corrientes | $10.9M | $8.3M | $2.4M | $2.1M | $2.9M | $2.7M | $8.1M | $2.9M | $2.0M | $3.7M |
| Deuda a Largo | 0 | 0 | 0 | $12000 | $287000 | 0 | $368000 | 0 | 0 | 0 |
| Pasivos Totales | $11.9M | $9.2M | $3.1M | $3.9M | $4.6M | $4.6M | $10.1M | $6.6M | $5.5M | $6.6M |
| Reservas | -$211.3M | -$220.6M | -$229.3M | -$234.1M | -$241.1M | -$250.4M | -$262.5M | -$270.7M | -$281.7M | -$292.1M |
| Patrimonio Neto | $14.4M | $5.4M | $8.4M | $5.2M | $25.8M | $17.2M | $5.7M | $8.8M | $3.9M | $2.9M |
| Deuda Total | $7.0M | $3.0M | 0 | $2.2M | $2.3M | $2.9M | $3.6M | $4.8M | $4.0M | $3.2M |
| Deuda Neta | $97000 | $2.4M | -$5.4M | $458000 | -$23.1M | -$11.4M | -$2.6M | $1.4M | $427000 | -$891000 |
| Capital Circulante | $5.1M | -$5.1M | $4.6M | $2.0M | $24.7M | $12.3M | -$869000 | $2.6M | $2.8M | $1.9M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$16.6M | -$9.3M | -$9.7M | -$4.8M | -$7.0M | -$9.3M | -$12.0M | -$8.3M | -$11.0M | -$10.4M |
| Amortizaciones | $1.9M | $1.1M | $109000 | $470000 | $498000 | $650000 | $963000 | $1.7M | $1.4M | $662000 |
| Compensación en Acciones | $273000 | $219000 | $42000 | $2000 | $45000 | 0 | $369000 | $291000 | $82000 | $2.0M |
| Cambio en Capital Circulante | $925000 | $870000 | -$1.4M | $403000 | -$194000 | -$483000 | -$55000 | -$1.6M | $286000 | -$356000 |
| Flujo de Caja Operativo | -$7.2M | -$4.7M | -$9.3M | -$6.4M | -$9.1M | -$10.1M | -$10.3M | -$14.1M | -$8.6M | -$8.6M |
| Inversiones (CapEx) | -$671000 | -$1.2M | -$61000 | -$147000 | -$360000 | -$3.7M | -$1.4M | -$530000 | -$690000 | -$189000 |
| Adquisiciones | $54000 | $49000 | 0 | 0 | 0 | $144000 | $303000 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -$2000 | 0 | -$133000 |
| Dividendos Pagados | -$6.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$7.8M | -$5.9M | -$9.4M | -$6.6M | -$9.5M | -$13.9M | -$11.7M | -$14.6M | -$9.3M | -$8.8M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | -26.3% | -99.2% | +625.3% | -13.8% | +2.0% | -0.8% | +337.1% | -52.6% | -18.3% | |
| Crecimiento Beneficio Neto (anual) | +43.8% | +7.3% | +44.6% | -46.5% | -32.4% | -29.3% | +31.4% | -33.5% | -55.0% | |
| Crecimiento BPA (anual) | +70.9% | +74.7% | +86.9% | +85.7% | -6.8% | -14.9% | +35.2% | +58.0% | +58.6% | |
| Cambio en Acciones (anual) | +93.0% | +286.6% | +305.3% | +1021.3% | +41.6% | +28.4% | +34.0% | +75.2% | +272.4% | |
| Crecimiento FCF (anual) | +25.2% | -60.4% | +30.0% | -43.9% | -46.4% | +15.9% | -25.5% | +36.3% | +6.1% | |
| Margen Bruto | 75.2% | 43.4% | 41.1% | 20.0% | 20.0% | 25.9% | 55.9% | 70.2% | 34.9% | -19.7% |
| Margen Operativo | -75.8% | -98.5% | -13806.3% | -957.0% | -1431.6% | -1752.5% | -1886.0% | -508.5% | -1127.4% | -1053.1% |
| Margen EBITDA | -54.6% | -98.5% | -8623.2% | -627.4% | -1099.2% | -1424.8% | -1840.1% | -251.2% | -771.3% | -947.9% |
| Margen Neto | -109.0% | -83.1% | -9107.4% | -696.2% | -1183.3% | -1536.1% | -2003.2% | -314.4% | -884.8% | -1678.1% |
| Margen FCF | -51.5% | -52.2% | -9904.2% | -955.3% | -1594.6% | -2288.9% | -1941.4% | -557.5% | -749.0% | -860.5% |
| Tasa Impositiva Efectiva | -37.8% | -13.5% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -64.8% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-15237.66 | $-5907.54 | $-2451.19 | $-423.03 | $-54.29 | $-56.13 | $-36.77 | $-34.44 | $-12.53 | $-3.16 |
| Dividendo por Acción | $12200.23 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $515 | $993 | $3646 | $15559 | $164065 | $206388 | $301610 | $384011 | $744781 | $2.8M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -565.55% |
| Rentabilidad sobre capital invertido | -149.36% |
| Rentabilidad sobre activos | -172.58% |
| Margen bruto | -4.63% |
| Margen operativo | -852.14% |
| Margen neto | -1303.40% |
Salud financiera
| Deuda / Patrimonio | 0.63 |
| Ratio corriente | 2.36 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -45.42 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -140.69 | -208.83 | -45.51 | -95.62 | -704.51 | -269.76 | -35.41 | -2.15 | -0.24 | -0.63 |
| P/VC | 162.47 | 357.99 | 46.88 | 89.13 | 199.65 | 154.09 | 102.37 | 3.34 | 0.67 | 3.66 |
| P/V | 153.37 | 173.53 | 4144.94 | 672.94 | 8672.80 | 4372.29 | 971.58 | 11.15 | 2.09 | 10.52 |
| Margen Bruto | 75.2% | 43.4% | 41.1% | 20.0% | 20.0% | 25.9% | 55.9% | 70.2% | 34.9% | -19.7% |
| Margen Operativo | -75.8% | -98.5% | -13806.3% | -957.0% | -1431.6% | -1752.5% | -1886.0% | -508.5% | -1127.4% | -1053.1% |
| Margen Neto | -109.0% | -83.1% | -9107.4% | -696.2% | -1183.3% | -1536.1% | -2003.2% | -314.4% | -884.8% | -1678.1% |
Empresas relacionadas: DHAI · HSCS · IINN · LFWD · PFSA · PTHL · RNAZ
Explorar sector: Healthcare · Medical - Devices
Más secciones de SINT: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones